KEY FACTS {#cesec1}
=========

 

Terminology {#cesec2}
===========

•Severe acute respiratory syndrome (SARS)

Etiology/Pathogenesis {#cesec3}
=====================

•Etiological agent○SARS coronavirus (SARS-CoV)•SARS can be transmitted by○Direct contact○Droplet○Airborne route

Clinical Issues {#cesec4}
===============

•Symptomatology○Flu-like symptoms•Prognosis○Mortality: ∼ 10%○More fatal cases in elderly patients \> 60 yr of age○Mortality in younger individuals \< 10%

Ancillary Tests {#cesec5}
===============

•Identification of viral particles by electron microscopy•Identification of viral particles by FISH or PCR

Top Differential Diagnoses {#cesec6}
==========================

•Avian influenza A (H5N1)○Avian influenza follows more aggressive course○Extensive necrosis and hemorrhage in lung parenchyma○Multinucleated giant cells are not commonly seen in avian influenza

Diagnostic Checklist {#cesec7}
====================

•Diffuse alveolar damage (DAD)•Organizing phase of DAD•Multinucleated giant cells

Congestion and EdemaSARS infection shows extensive areas of congestion, edema ![](black-curve-9780323377157.gif), and hyaline membranes ![](black-solid-9780323377157.gif). All these features are compatible with diffuse alveolar damage (DAD) caused by SARS-CoV. Focal Pneumocyte Type II HyperplasiaSARS shows the classic features of hyaline membranes ![](black-curve-9780323377157.gif) and pneumocyte type II hyperplasia ![](black-open-9780323377157.gif), which are compatible with DAD. DAD ChangesIn other areas, features of DAD are more apparent. Note the presence of type II pneumocyte hyperplasia ![](black-open-9780323377157.gif) and hyaline membranes ![](black-curve-9780323377157.gif) . Hyaline MembranesAlveolar walls entirely lined by a hyaline membrane are commonly seen in fulminant cases of DAD as shown here.

TERMINOLOGY {#cesec8}
===========

Abbreviations {#cesec9}
-------------

•Severe acute respiratory syndrome (SARS)

Definitions {#cesec10}
-----------

•Infectious viral disease

ETIOLOGY/PATHOGENESIS {#cesec11}
=====================

Infectious Agents {#cesec12}
-----------------

•SARS coronavirus (SARS-CoV)•Single-stranded RNA virus•Virus has also been isolated from○Urine○Feces

Pathogenesis {#cesec13}
------------

•Highly complex•May involve○Immune system○Hyperinduction of chemokines and cytokines○Insufficient interferon reaction○Compromised cellular immune response○Metallopeptidase (ACE2) identified as functional receptor for SARS-CoV•SARS can be transmitted by○Direct contact○Droplet○Airborne route

CLINICAL ISSUES {#cesec14}
===============

Epidemiology {#cesec15}
------------

•Incidence○Difficult to establish but at end of initial epidemic of 2003, \> 8,000 probable cases had been reported•Age○Affects any age group•Sex○No gender predilection•Ethnicity○Probably more common in China

Presentation {#cesec16}
------------

•Flu-like symptoms•Fever•Cough•Chills•Malaise•Shortness of breath

Treatment {#cesec17}
---------

•No specific treatment•Some patients treated with steroids•Antiviral therapy

Prognosis {#cesec18}
---------

•Mortality: ∼ 10%•Elderly patients (\> 60 yr of age) may account for 50% of fatal cases•In younger patients, mortality has been estimated to be \< 10%•Mortality appears to be higher in males than females

MACROSCOPIC {#cesec19}
===========

General Features {#cesec20}
----------------

•Congested lungs

MICROSCOPIC {#cesec21}
===========

Histologic Features {#cesec22}
-------------------

•Diffuse alveolar damage (DAD)○Pneumocyte type II hyperplasia○Hyaline membranes•Organizing phase of DAD○Hyaline membranes○Fibroblastic plugs in alveolar spaces○Pneumocyte type II hyperplasia•Bronchiolitis obliterans and organizing pneumonia•Multinucleated giant cells•Other organs may also be affected, including○Gastrointestinal tract○Hematopoietic○Central nervous system○Skeletal muscle○Heart○Thyroid○Testes

ANCILLARY TESTS {#cesec23}
===============

In Situ Hybridization {#cesec24}
---------------------

•Identification of viral particles

PCR {#cesec25}
---

•Identification of viral particles

Electron Microscopy {#cesec26}
-------------------

•Identification of viral particles

DIFFERENTIAL DIAGNOSIS {#cesec27}
======================

Avian Influenza A (H5N1) {#cesec28}
------------------------

•Although it also shows DAD, avian influenza follows more aggressive course with marked necrosis and hemorrhage in lungs•Multinucleated giant cells present in SARS are not present in avian influenza

DIAGNOSTIC CHECKLIST {#cesec29}
====================

Pathologic Interpretation Pearls {#cesec30}
--------------------------------

•Diffuse alveolar damage•Organizing phase of DAD•Multinucleated giant cells
